Re: Guidence regarding scm

From: Shankar Lanke Date: May 28, 2015 technical Source: mail-archive.com
Muhammad, Based on your earlier email, I may suggest you to focus again on your results. Make sure, your parameter estimates, error estimates, RSE, CV, OFV, GOF are in accord. rRUN GAM once. When you are perform forward addition, add one covariate at a time on CL, based on the results add the covariates combination. Do the same for V1 (most likely wt only), sometimes you may not get WT too. But when you apply WT as a covariate on CL & Vd you may get better model. Your data may dictate WT as a covariate on V2. Bakcward elimination, p<0.001 wthi chi sq 10.83 will be good. Take a look at Nonlinear Mixed Effects Models:Theory chapter in Bonate's book.( https://books.google.com/books/about/Pharmacokinetic_Pharmacodynamic_Modeling.html?id=kfS5oLko95kC&hl=en) else chapter 5 section 5.7 in Jill Fideler-Kelly's book.
Quoted reply history
On Thu, May 28, 2015 at 9:49 AM, Muhammad Usman <[email protected]> wrote: > Dear NM Users, > > I have developed a model and want to perform SCM by using CRCL, AGE and WT > as continuous covariates and SEX as categorical covariate on CL, V1 and V2. > Below is my control stream which I wrote for running the model. Can someone > guide me is it Ok to use this control stream for performing stepwise > covariate modelling. If there is mistake (which I hope there is with TVV1 = > THETA(2) * WT and TVV2 = THETA(3) * WT) then how can I resolve this problem > because when I omit influence of WT on V1 and V2 in model the results are > worrisome. > > $PROBLEM PK > > $INPUT ID TIME DV AMT CMT MDV EVID WT CRCL AGE SEX > > $DATA Vanco_016_iv_1.csv IGNORE=@ > > $SUBROUTINES ADVAN3 TRANS4 > > $PK > > TVCL = THETA(1) * (1+THETA(6)*CRCL) > > TVV1 = THETA(2) * WT > > TVV2 = THETA(3) * WT > > TVQ = THETA(4) > > CL = TVCL*EXP(ETA(1)) > > V1 = TVV1 > > V2 = TVV2 > > Q = TVQ > > S1 = V1 > > $ERROR > > IPRED = F > > W=F*THETA(5) > > IRES=DV-IPRED > > IWRES=IRES/W > > Y=F+W*EPS(1) ; Combined residual random error > > $THETA > > (0,0.5,7) ; CL > > (0,0.3,0.9) ; V1 > > 0.732 FIX ; V2 > > 0.5 ; Q > > (0,0.44) ; Proportional error > > 0.01 FIX ; Proportional change in CL > > $OMEGA > > 0.07 ; IIV CL > > $SIGMA 1 FIX > > $EST SIG=4 MAX=9999 PRINT=5 NOABORT METHOD=1 INTER MSFO=MSFB1 > > $TABLE ID TIME DV AMT CMT MDV EVID WT CRCL AGE SEX IPRED IWRES ETA1 CWRES > PRED > > NOPRINT ONEHEADER NOAPPEND FILE= mytab3 ;Xpose > > $COV > Best regards > > -- > *Muhammad Usman* > PhD Scholar > Westfälische Wilhelms-Universität Münster > Institut für Pharmazeutische und Medizinische Chemie > - Klinische Pharmazie - > Corrensstrasse 48 > 48149 Münster > > Room No. A120.209 > > Phone: +49 251/8332171 > > Mob # +49 176 70962067 > -- Regards, Shankar Lanke Ph.D. Assistant Professor Department of Pharmaceutical Sciences College of Pharmacy The University of Findlay (O) 419-434-5448 Fax# 419-434-4390
May 28, 2015 Muhammad Usman Guidence regarding scm
May 28, 2015 Shankar Lanke Re: Guidence regarding scm
Jun 01, 2015 Muhammad Usman Guidence regarding scm
Jun 01, 2015 Kajsa Harling Re: Guidence regarding scm